Short answer

Designers and researchers involved in health technology and public health initiatives should consider the implications of updated screening age recommendations in their product development and strategy planning.

Field: Commercial Production
Source: CA A Cancer Journal for Clinicians (2018)
Method: Systematic evidence review and microsimulation modeling
Evidence: Strong recommendation for screening from age 45, qualified recommendation for specific age groups.

Shifting the recommended age for colorectal cancer screening from 50 to 45 years can significantly reduce cancer incidence and mortality. This commercial production research insight is drawn from a 2018 study published in CA A Cancer Journal for Clinicians. Using Systematic evidence review and microsimulation modeling, researchers explored how this design variable affects real-world outcomes. The key design takeaway: Designers and researchers involved in health technology and public health initiatives should consider the implications of updated screening age recommendations in their product development and strategy planning.

Study

Commercial ProductionHigh ImpactStrong recommendation for screening from age 45, qualified recommendation for specific age groups.

Age 45: The New Starting Line for Colorectal Cancer Screening

Shifting the recommended age for colorectal cancer screening from 50 to 45 years can significantly reduce cancer incidence and mortality.

CA A Cancer Journal for Clinicians · 2018

Key Findings

01Screening with various methods is associated with significant reductions in colorectal cancer incidence and mortality.
02Modeling analyses identified age 45 as an efficient age to begin screening.
03The ACS recommends screening for average-risk adults aged 45 and older.

Application

Design takeaway

How to apply

Consider the impact of age-related health recommendations on the design and marketing of health screening services and related technologies.

Project actions

01When researching health guidelines, look for the reasoning behind the recommendations.
02Consider how data modeling can be used to predict the impact of design changes.

Method & Evidence

AimWhat is the optimal age to initiate colorectal cancer screening for average-risk adults to maximize incidence and mortality reduction?

MethodSystematic evidence review and microsimulation modeling

ProcedureThe American Cancer Society (ACS) reviewed existing literature on colorectal cancer screening and conducted new microsimulation modeling analyses, including evaluations of screening initiation age by race and sex, and incorporated changes in US colorectal cancer incidence. Recommendations were developed using the GRADE criteria.

ContextColorectal cancer screening guidelines for average-risk adults in the United States.

Variables

IVAge at which screening begins

DVColorectal cancer incidence and mortality rates

CVRisk factors for colorectal cancer, screening methods available

Strengths & Limitations

Strengths

+Utilizes robust modeling techniques to predict population-level outcomes.
+Based on a comprehensive review of existing scientific literature.

Limitations

The study relies on modeling, which is an estimation, and individual health factors can vary greatly.

Reliability & validity

The reliability of the findings depends on the accuracy of the microsimulation models and the quality of the systematic evidence review. Validity is supported by the consensus of the ACS Guideline Development Group.

Think critically

How might the cost and accessibility of screening impact the implementation of this new guideline across different socioeconomic groups?

Design Principles

"Proactive health interventions should be informed by robust data modeling and evidence reviews to optimize population health outcomes."

This guideline update demonstrates how data-driven modeling can inform public health policy and impact population-level health outcomes. It highlights the importance of reassessing established screening protocols based on evolving evidence and predictive analytics to optimize preventative healthcare strategies.

What This Means for Your Design

Scientists found that starting cancer checks for the colon and rectum at age 45, instead of 50, can help prevent more cases and save more lives.

How to use in your project

1.Reference this study when discussing the impact of evidence-based recommendations on design practice in health-related fields.

Add to My Project

Quick Cite

Paragraph starter

The American Cancer Society's 2018 guideline update, based on systematic evidence review and microsimulation modeling, recommends initiating colorectal cancer screening for average-risk adults at age 45, a shift from previous guidelines, aiming to significantly reduce cancer incidence and mortality through early detection and polyp removal.

Source

CA A Cancer Journal for Clinicians

Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society

journal · 2018

View source

Questions About This Research

What does the research say about age 45: the new starting line for colorectal cancer screening?: Designers and researchers involved in health technology and public health initiatives should consider the implications of updated screening age recommendations in their product development and strategy planning. Evidence: CA A Cancer Journal for Clinicians (2018).
Why does "Age 45: The New Starting Line for Colorectal Cancer Screening" matter for design?: This guideline update demonstrates how data-driven modeling can inform public health policy and impact population-level health outcomes. It highlights the importance of reassessing established screening protocols based on evolving evidence and predictive analytics to optimize preventative healthcare strategies.
How can designers apply this research?: Designers and researchers involved in health technology and public health initiatives should consider the implications of updated screening age recommendations in their product development and strategy planning.
What were the main findings?: Screening with various methods is associated with significant reductions in colorectal cancer incidence and mortality.. Modeling analyses identified age 45 as an efficient age to begin screening.. The ACS recommends screening for average-risk adults aged 45 and older.
What research method was used?: Systematic evidence review and microsimulation modeling.
How strong is the evidence?: Evidence strength is rated Strong recommendation for screening from age 45, qualified recommendation for specific age groups., based on a 2018 journal from CA A Cancer Journal for Clinicians.
What should I do differently in my next project?: Consider the impact of age-related health recommendations on the design and marketing of health screening services and related technologies.
What are the limitations?: The recommendation to begin screening at age 45 is qualified, while the recommendation for screening adults aged 50 and older is strong. Decisions for individuals aged 76-85 should be individualized.